We are live on
!
Find out more
Handelsbanken Fonder Portfolio holdings
AUM
$35.1B
1-Year Est. Return
47.76%
This Fund
S&P 500
This Quarter
Est. Return
+8.86%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$18.7B
AUM Growth
+$1.36B
(+7.9%)
Cap. Flow
+$221M
Cap. Flow
% of AUM
1.18%
Top 10 Holdings %
Top 10 Hldgs %
25.29%
Holding
1,658
New
94
Increased
608
Reduced
275
Closed
90
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$68M |
| 2 |
Linde
LIN
|
+$61M |
| 3 |
Edwards Lifesciences
EW
|
+$55.5M |
| 4 |
Idexx Laboratories
IDXX
|
+$46.4M |
| 5 |
Array Technologies
ARRY
|
+$45.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$98.4M |
| 2 |
Alibaba
BABA
|
+$83.5M |
| 3 |
East-West Bancorp
EWBC
|
+$62.6M |
| 4 |
NVIDIA
NVDA
|
+$58.3M |
| 5 |
Thermo Fisher Scientific
TMO
|
+$48.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.65% |
| 2 | Healthcare | 21.65% |
| 3 | Industrials | 10.6% |
| 4 | Consumer Discretionary | 9.49% |
| 5 | Financials | 9.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
Dentsply Sirona
XRAY
$2.31B
| $1.69M | 0.01% |
42,200
| – | – |
|
577
Tencent Music
TME
$14.2B
| $1.68M | 0.01% |
227,900
| – | – |
|
578
Procore
PCOR
$9.45B
| $1.67M | 0.01% |
25,700
+17,000
| +195% | +$1,000K |
|
|
WCC
579
WESCO International
WCC
$17.5B
| $1.66M | 0.01% |
9,293
-1,000
| -10% | -$146K |
|
580
Bio-Rad Laboratories Class A
BIO
$9.66B
| $1.66M | 0.01% |
4,372
-200
| -4% | -$81.4K |
|
581
Coinbase
COIN
$40.6B
| $1.66M | 0.01% |
23,151
+13,492
| +140% | +$805K |
|
582
Match Group
MTCH
$8.56B
| $1.65M | 0.01% |
39,481
+20,970
| +113% | +$767K |
|
583
Crown Holdings
CCK
$12.9B
| $1.65M | 0.01% |
19,000
| – | – |
|
584
Charles River Laboratories
CRL
$13.4B
| $1.65M | 0.01% |
7,837
+800
| +11% | +$159K |
|
585
Neurocrine Biosciences
NBIX
$15.3B
| $1.64M | 0.01% |
17,367
-200
| -1% | -$19.5K |
|
586
Steris
STE
$23B
| $1.64M | 0.01% |
+7,277
| New | +$1.46M |
|
587
Fortune Brands Innovations
FBIN
$5.78B
| $1.63M | 0.01% |
22,700
+9,800
| +76% | +$623K |
|
588
Knight Transportation
KNX
$11.9B
| $1.63M | 0.01% |
29,300
-100
| -0.3% | -$5.58K |
|
589
United Therapeutics
UTHR
$21.5B
| $1.61M | 0.01% |
7,300
| – | – |
|
590
American Financial Group
AFG
$12.1B
| $1.6M | 0.01% |
13,500
+2,400
| +22% | +$283K |
|
591
Ingredion
INGR
$6.63B
| $1.6M | 0.01% |
15,130
+6,800
| +82% | +$723K |
|
592
Lithia Motors
LAD
$8.32B
| $1.6M | 0.01% |
5,258
+700
| +15% | +$168K |
|
593
Sarepta Therapeutics
SRPT
$1.95B
| $1.59M | 0.01% |
13,902
+900
| +7% | +$116K |
|
|
BLD
594
DELISTED
TopBuild
BLD
| $1.58M | 0.01% |
5,937
-600
| -9% | -$132K |
|
595
Tetra Tech
TTEK
$9.33B
| $1.57M | 0.01% |
48,045
+13,500
| +39% | +$397K |
|
|
APLS
596
DELISTED
Apellis Pharmaceuticals
APLS
| $1.57M | 0.01% |
17,200
+2,200
| +15% | +$190K |
|
597
Lennox International
LII
$14.5B
| $1.56M | 0.01% |
4,800
-900
| -16% | -$254K |
|
598
Gen Digital
GEN
$17.7B
| $1.55M | 0.01% |
83,782
+8,064
| +11% | +$141K |
|
599
GlobalFoundries
GFS
$28.9B
| $1.55M | 0.01% |
24,042
+11,999
| +100% | +$726K |
|
600
Lear
LEA
$8.16B
| $1.54M | 0.01% |
10,700
+1,900
| +22% | +$251K |
|
Similar funds
GAM
Handelsbanken Fonder's Q2 2023 Portfolio in Review
As of Q2 2023, Handelsbanken Fonder held 1,658 positions worth $18.7B, up 7.9% from $17.3B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Handelsbanken Fonder's Q2 2023 filing shows 94 new, 608 increased, 275 reduced and 90 closed positions. Its largest new stake was Linde: 166,967 shares worth $63.6M. The largest sale was Berkshire Hathaway Class B, an estimated $98.4M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 28% a quarter earlier, followed by Healthcare and Industrials.
- Handelsbanken Fonder's largest Q2 2023 buy was Linde: 166,967 shares worth $63.6M.
- Handelsbanken Fonder added most to Microsoft in Q2 2023, an estimated $68M increase.
- Handelsbanken Fonder's biggest Q2 2023 reduction was Alibaba, cutting an estimated $83.5M.
- Handelsbanken Fonder fully exited Berkshire Hathaway Class B in Q2 2023, selling an estimated $98.4M.
- Handelsbanken Fonder's ten largest holdings make up 25% of its $18.7B portfolio in Q2 2023.
- Handelsbanken Fonder opened 94 new positions and closed 90 in Q2 2023.
- Handelsbanken Fonder's portfolio value rose 7.9% quarter-over-quarter to $18.7B.
Based on Handelsbanken Fonder's 13F filing for Q2 2023, filed 2 Aug 2023.